{"id":"W7009387131","doi":"","title":"Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2014 - Today's Market News (MARKCOMM) News","year":2014,"lang":"en","type":"other","venue":"","topic":"Diverse Perspectives in Modern Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Financial market; Fiscal year; Economic forecasting","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002233103,0.000778574,0.0006868744,0.001750157,0.001484197,0.007650246,0.001225495,0.004030952,0.2980729],"category_scores_gemma":[0.005741194,0.0003196473,0.0007313535,0.001156696,0.000588574,0.002100137,0.001446987,0.00392768,0.1741684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00255073,"about_ca_system_score_gemma":0.00475282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009993694,"about_ca_topic_score_gemma":0.02376044,"domain_scores_codex":[0.9979633,0.0001167977,0.00005396962,0.0001211871,0.001403931,0.0003408124],"domain_scores_gemma":[0.9966518,0.0003139403,0.0002740065,0.0001548669,0.001704738,0.0009007514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000536308,0.00003003401,0.00006940996,0.000021817,0.00000264009,0.00002848291,0.000003975093,0.00002128711,0.00006146322,0.001180379,0.9889393,0.009587358],"study_design_scores_gemma":[0.00004095635,0.00004427475,0.0009494309,0.00006104981,0.000005018113,0.00004413584,0.00002476091,0.0001332968,0.0003789984,0.001056093,0.9972524,0.000009603289],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.001348607,0.003025081,0.0005415811,0.04351953,0.02125923,0.0002115359,0.0162211,0.001640194,0.9122333],"genre_scores_gemma":[0.003285729,0.001150156,0.0002148699,0.004817845,0.002464952,0.00003948003,0.003701456,0.0002967383,0.9840288],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.7019271,"threshold_uncertainty_score":0.9971531,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04435283948076365,"score_gpt":0.2883628395606627,"score_spread":0.244010000079899,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}